Moreover, IFNγ‐induced PD‐L1 expression is blocked by tofacitinib, which is a JAK‐STAT inhibitor broadly used in the treatment of rheumatoid arthritis.21 This evidence concerns the gene SOAT1 and rheumatoid arthritis.